Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 4, 2013, Pages 545-549

  Hassan, Ameer E ^a   Chaudhry, Saqib A ^a   Jani, Vishal ^a   Grigoryan, Mikayel ^a   Khan, Asif A ^a   Adil, Malik M ^a   Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute ischemic stroke; cerebral infarction; obesity; outcomes; thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD CLOT LYSIS; BODY WEIGHT; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PNEUMONIA; PRIORITY JOURNAL; RATING SCALE; SEPSIS; SEX RATIO; SUBARACHNOID HEMORRHAGE; TEACHING; TREATMENT OUTCOME; UNITED STATES; URINARY TRACT INFECTION; CEREBRAL HEMORRHAGE; CHI SQUARE DISTRIBUTION; COMPLICATION; DISABILITY; FIBRINOLYTIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; RISK; RISK FACTOR; STATISTICAL MODEL; STROKE; TIME;

ADMINISTRATION, INTRAVENOUS; AGED; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DISABILITY EVALUATION; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PATIENT DISCHARGE; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 84877066795     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.01.022     Document Type: Article

References (24)

1. D.L. Reich, S. Hossain, and M. Krol Predictors of hypotension after induction of general anesthesia Anesth Analg 101 2005 622 628
2. R.E. Kennedy, G. Howard, and R.C. Go Association between family risk of stroke and myocardial infarction with prevalent risk factors and coexisting diseases Stroke 43 2012 974 979
3. T.G. Brott, E.C. Haley Jr., and D.E. Levy Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes Stroke 23 1992 632 640
4. E.C. Haley Jr., D.E. Levy, and T.G. Brott Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset Stroke 23 1992 641 645
5. W.C. Sternbergh 3rd, and B. Adelman The temporal relationship between endothelial cell dysfunction and skeletal muscle damage after ischemia and reperfusion J Vasc Surg 16 1992 30 39
6. G.A. Rosito, R.B. D'Agostino, and J. Massaro Association between obesity and a prothrombotic state: The Framingham Offspring Study Thromb Haemost 91 2004 683 689
7. W.G. Tekle, S.A. Chaudhry, and A.E. Hassan Drip-and-ship thrombolytic treatment paradigm among acute ischemic stroke patients in the United States Stroke 43 2012 1971 1974
8. A.I. Qureshi, S.A. Chaudhry, and G.J. Rodriguez Outcome of the 'drip-and-ship' paradigm among patients with acute ischemic stroke: Results of a statewide study Cerebrovasc Dis Extra 2 2012 1 8
9. A.I. Qureshi, P. Harris-Lane, and F. Siddiqi International classification of diseases and current procedural terminology codes underestimated thrombolytic use for ischemic stroke J Clin Epidemiol 59 2006 856 858
10. C.Z. Lee, and W.L. Young Anesthesia for endovascular neurosurgery and interventional neuroradiology Anesthesiol Clin 30 2012 127 147
11. M.T. Froehler, J.T. Fifi, and A. Majid Anesthesia for endovascular treatment of acute ischemic stroke Neurology 79 13 Suppl 1 2012 S167 S173
12. K.C. Matter, S.A. Sinclair, and S.G. Hostetler A comparison of the characteristics of injuries between obese and non-obese inpatients Obesity (Silver Spring) 15 2007 2384 2390
13. Agency of Healthcare Research and Quality Children's Hospitals and Related Institutions (NACHRI) website. APR-DRG classification software-Overview. Available at http://www.ahrq.gov/qual/mortality/Hughessumm.pdf. Accessed February 10, 2013.
14. R. Khatri, N. Tariq, and G. Vazquez Outcomes after nontraumatic subarachnoid hemorrhage at hospitals offering angioplasty for cerebral vasospasm: A national level analysis in the United States Neurocrit Care 15 2011 34 41
15. Shukla R, Fisher R, Fisher R. Testing of 3M's APR-DRG risk adjustment for hospital mortality outcomes. Abstr Academy for Health Services Research and Health Policy Meeting 2002;19:11.
16. A.I. Qureshi, S.A. Chaudhry, and A.E. Hassan Thrombolytic treatment of patients with acute ischemic stroke related to underlying arterial dissection in the United States Arch Neurol 68 2011 1536 1542
17. M.A. Sloan, and J.M. Gore Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis Am J Cardiol 69 1992 21A 38A
18. P.P. De Jaegere, A.A. Arnold, and A.H. Balk Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors J Am Coll Cardiol 19 1992 289 294
19. M. Lou, and M. Selim Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients? Cerebrovasc Dis 27 2009 84 90
20. M. Fareed, K. Suri, and A.I. Qureshi Recruitment of ischemic stroke patients in clinical trials in general practice and implications for generalizability of results J Vasc Interv Neurol 5 2012 27 32
21. H. Sarikaya, F. Elmas, and M. Arnold Impact of obesity on stroke outcome after intravenous thrombolysis Stroke 42 2011 2330 2332
22. D.E. Levy, T.G. Brott, and E.C. Haley Jr. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke Stroke 25 1994 291 297
23. S.C. Bansal, B.R. Bansal, and J.P. Boland Blocking and unblocking serum factors in neoplasia Curr Top Microbiol Immunol 75 1976 45 76
24. A.I. Qureshi, S.A. Chaudhry, and B.L. Sapkota Discharge destination as a surrogate for Modified Rankin Scale defined outcomes at 3- and 12-months poststroke among stroke survivors Arch Phys Med Rehabil 93 2012 1408 1413.e1